Lv35
227 积分 2022-02-22 加入
Discovery of a Highly Potent, N-terminal Domain-targeting degrader of AR-FL/AR-V7 for the treatment of Prostate Cancer
1天前
已完结
COPD lung studies of Nrf2 expression and the effects of Nrf2 activators
4天前
已完结
NRF2 Inhibitors: Recent Progress, Future Design and Therapeutic potential
8天前
已完结
Structure-Guided Conformational Restriction Leading to High-Affinity, Selective, and Cell-Active Tetrahydroisoquinoline-Based Noncovalent Keap1-Nrf2 Inhibitors
11天前
已完结
Inhibiting the Keap1/Nrf2 Protein‐Protein Interaction with Protein‐Like Polymers
11天前
已完结
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
11天前
已完结
Identification of Oral Bioavailable Coumarin Derivatives as Potential AR Antagonists Targeting Prostate Cancer
14天前
已完结
Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase
18天前
已完结
Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500)
23天前
已完结
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
30天前
已完结
皖公网安备34019202002308
